Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Edit custom filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1966 1
1971 1
1972 5
1973 6
1974 5
1975 5
1976 3
1977 4
1978 1
1979 4
1982 2
1983 4
1984 3
1986 2
1987 7
1988 3
1989 7
1990 5
1991 5
1992 2
1993 4
1994 4
1995 2
1996 5
1997 4
1998 2
1999 1
2000 4
2001 4
2002 2
2003 3
2004 3
2006 4
2007 4
2008 1
2010 1
2013 1
2014 1
2015 1
2016 1
2018 1
2020 1
2023 1
2026 0

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

127 results

Results by year

Filters applied: . Clear all
Page 1
Benztropine and suicide attempts and intentional self-harm.
Gibbons RD, Hur K, Lavigne JE, Mann JJ. Gibbons RD, et al. Psychiatry Res. 2023 Feb;320:115054. doi: 10.1016/j.psychres.2023.115054. Epub 2023 Jan 7. Psychiatry Res. 2023. PMID: 36638693 Clinical Trial.
BACKGROUND: This large-scale pharmacoepidemiologic study was conducted to confirm a previous signal for decreased risk of suicide attempt following prescription fills for benztropine. METHODS: We used a within-person exposure-only cohort design to study the dynamic associa …
BACKGROUND: This large-scale pharmacoepidemiologic study was conducted to confirm a previous signal for decreased risk of suicide attempt fo …
Benztropine prophylaxis of dystonic reactions.
Stern TA, Anderson WH. Stern TA, et al. Psychopharmacology (Berl). 1979 Mar 28;61(3):261-2. doi: 10.1007/BF00432269. Psychopharmacology (Berl). 1979. PMID: 36644 Clinical Trial.
Antihistaminics in idiopathic dystonia.
Lang AE. Lang AE. Arch Neurol. 1996 May;53(5):405. doi: 10.1001/archneur.1996.00550050027012. Arch Neurol. 1996. PMID: 8624213 Clinical Trial. No abstract available.
Dosage of haloperidol for mania.
Rifkin A, Doddi S, Karajgi B, Borenstein M, Munne R. Rifkin A, et al. Br J Psychiatry. 1994 Jul;165(1):113-6. doi: 10.1192/bjp.165.1.113. Br J Psychiatry. 1994. PMID: 7953013 Clinical Trial.
METHOD: Forty-seven newly admitted in-patients with mania were randomised to receive 10, 30, or 80 mg a day of oral haloperidol, under double-blind conditions for up to six weeks. All subjects received prophylactic benztropine. RESULTS: Repeated-measures analysis of varian …
METHOD: Forty-seven newly admitted in-patients with mania were randomised to receive 10, 30, or 80 mg a day of oral haloperidol, under doubl …
The effect of benztropine on haloperidol-induced dystonia, clinical efficacy and pharmacokinetics: a prospective, double-blind trial.
Goff DC, Arana GW, Greenblatt DJ, Dupont R, Ornsteen M, Harmatz JS, Shader RI. Goff DC, et al. J Clin Psychopharmacol. 1991 Apr;11(2):106-12. J Clin Psychopharmacol. 1991. PMID: 2056136 Clinical Trial.
Twenty-nine inpatients with major psychotic disorders were treated for 14 days with a clinician-determined dose of haloperidol and with either benztropine or placebo given by double-blind random assignment on days 1 through 7. No differences were noted in haloperidol mean …
Twenty-nine inpatients with major psychotic disorders were treated for 14 days with a clinician-determined dose of haloperidol and with eith …
Efficacy of benztropine therapy for drooling.
Camp-Bruno JA, Winsberg BG, Green-Parsons AR, Abrams JP. Camp-Bruno JA, et al. Dev Med Child Neurol. 1989 Jun;31(3):309-19. doi: 10.1111/j.1469-8749.1989.tb04000.x. Dev Med Child Neurol. 1989. PMID: 2666205 Clinical Trial.
This study assessed the efficacy of synthetic anticholinergic benztropine and incidence of side-effects in 20 developmentally-disabled patients with severe drooling. The double-blind, placebo-controlled, crossover protocol included one-week baseline, two-week placebo and t …
This study assessed the efficacy of synthetic anticholinergic benztropine and incidence of side-effects in 20 developmentally-disable …
The withdrawal of benztropine mesylate in chronic schizophrenic patients.
Baker LA, Cheng LY, Amara IB. Baker LA, et al. Br J Psychiatry. 1983 Dec;143:584-90. doi: 10.1192/bjp.143.6.584. Br J Psychiatry. 1983. PMID: 6362765 Clinical Trial.
In this double-blind, four-week study, 28 chronic schizophrenic patients receiving neuroleptic medication plus the antiparkinsonian drug, benztropine mesylate, were either switched to placebo or maintained on benztropine. Patients withdrawn from benztropine r …
In this double-blind, four-week study, 28 chronic schizophrenic patients receiving neuroleptic medication plus the antiparkinsonian drug, …
Parkinson's disease: Cogentin with Sinemet, a better response.
Tourtellotte WW, Potvin AR, Syndulko K, Hirsch SB, Gilden ER, Potvin JH, Hansch EC. Tourtellotte WW, et al. Prog Neuropsychopharmacol Biol Psychiatry. 1982;6(1):51-5. doi: 10.1016/s0364-7722(82)80107-0. Prog Neuropsychopharmacol Biol Psychiatry. 1982. PMID: 7202230 Clinical Trial.
Both the neurologist's and the patient's global assessments of treatment efficacy indicated that Sinemet plus benztropine mesylate resulted in significantly greater improvement than Sinemet plus placebo. 4. Qualitative and quantitative evaluations of relevant neurologic fu …
Both the neurologist's and the patient's global assessments of treatment efficacy indicated that Sinemet plus benztropine mesylate re …
Effectiveness and cost of olanzapine and haloperidol in the treatment of schizophrenia: a randomized controlled trial.
Rosenheck R, Perlick D, Bingham S, Liu-Mares W, Collins J, Warren S, Leslie D, Allan E, Campbell EC, Caroff S, Corwin J, Davis L, Douyon R, Dunn L, Evans D, Frecska E, Grabowski J, Graeber D, Herz L, Kwon K, Lawson W, Mena F, Sheikh J, Smelson D, Smith-Gamble V; Department of Veterans Affairs Cooperative Study Group on the Cost-Effectiveness of Olanzapine. Rosenheck R, et al. JAMA. 2003 Nov 26;290(20):2693-702. doi: 10.1001/jama.290.20.2693. JAMA. 2003. PMID: 14645311 Clinical Trial.
INTERVENTIONS: Patients were randomly assigned to receive flexibly dosed olanzapine, 5 to 20 mg/d, with prophylactic benztropine, 1 to 4 mg/d (n = 159); or haloperidol, 5 to 20 mg/d (n = 150), for 12 months. ...CONCLUSION: Olanzapine does not demonstrate advantages compare …
INTERVENTIONS: Patients were randomly assigned to receive flexibly dosed olanzapine, 5 to 20 mg/d, with prophylactic benztropine, 1 t …
Treatment of neuroleptic-resistant schizophrenic relapse.
Kinon BJ, Kane JM, Johns C, Perovich R, Ismi M, Koreen A, Weiden P. Kinon BJ, et al. Psychopharmacol Bull. 1993;29(2):309-14. Psychopharmacol Bull. 1993. PMID: 7904762 Clinical Trial.
A sample of 156 acutely ill schizophrenic, schizoaffective, and schizophreniform patients who had been hospitalized recently in an acute-care inpatient facility were treated openly with fluphenazine (FPZ) 20 mg/day and with prophylactic benztropine for 4 weeks. Those subje …
A sample of 156 acutely ill schizophrenic, schizoaffective, and schizophreniform patients who had been hospitalized recently in an acute-car …
127 results